Florence Thibaut
Editor-in-chief
Florence Thibaut
MD, PhD

Florence Thibaut, MD, PhD, Psychiatrist and Endocrinologist, is Professor of Psychiatry at University Hospital Cochin-Tarnier and Faculty of Medicine Paris Descartes (University Sorbonne-Paris Cité), Paris, France. She is a member of the INSERM Unit 894 (Centre Psychiatry and Neurosciences).

Her main areas of interest are psychotic and addictive disorders.

Prof Thibaut is Honorary President of the World Federation of Societies of Biological Psychiatry, and also Past President of the French Association for Biological Psychiatry.

She is currently an expert for the WHO (addictions).

She is member of several editorial boards of international journals.

She is author or coauthor of more than 190 papers (126 indexed in PubMed), 4 books, and 50 book chapters, and has been an invited speaker at many national and international meetings (more than 400).

César Carvajal
César Carvajal
MD, Clínica Universidad de los Andes, Santiago, Chile

Dr. César Carvajal graduated from Pontificia Universidad Católica de Chile School of Medicine in 1981 and specializes in psychiatry. Trained in biological psychiatry at Universidad de Navarra, España. Has been practicing clinical psychiatry from 1984 and is Professor of Psychiatry in Clínica Universidad de los Andes at Santiago, Chile

Marc-Antoine Crocq
Marc-Antoine Crocq
MD, Medical Center, Rouffach, France

Marc-Antoine Crocq, MD, psychiatrist, coordinates mental health services for adolescents, young adults, and students in the community and at the University of Upper Alsace.

He is the primary coordinator of the French translation of the DSM-5. He is a member of the Terminology Committee at the French Ministry of Health. He has over 70 articles listed in PubMed on the history of psychiatry, psychiatric nosology, and biological psychiatry.

Michael Davidson
Michael Davidson
MD, Chaim Sheba Medical Center, Tel-Hashomer, Israel

Further details soon

Peter Falkai
Peter Falkai
MD, PhD, Department of Psychiatry, University of Munich, Germany

Peter Falkai has been working in the field of psychiatry for 30 years. His main research interest is focused on the neurobiology of psychotic disorders, namely schizophrenia. He holds the position of Chair of the Department of Psychiatry and Psychotherapy of the University of Munich.

Prof. Falkai has been leading multidisciplinary teams of researchers, allowing the use of techniques ranging from functional imaging to gene expression in human post-mortem-tissue. His clinical and research expertise focuses continuously on the neurobiological origins and pathomorphological aspects as well as on causal treatment options of psychotic disorders.

Prof. Falkai has managed to obtain state funding for numerous of his research projects and has also received various research awards. He has been involved in creating treatment guidelines for schizophrenia for the German Society of Psychiatry, Psychotherapy and Nervous Diseases (DGPPN) and for the World Federation of the Biological Societies (WFSBP). He was Chairman of the DGPPN from 2011-2012 and is currently president-elect of the European Psychiatric Association (EPA).

Deborah Morris-Rosendahl
Deborah Morris-Rosendahl
PhD, National Heart and Lung Institute, Imperial College London, UK

Further details soon

Dieter Naber
Dieter Naber
MD, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany

Further details soon

Rajesh Parikh
Rajesh Parikh
MD, Jasklok Hospital and Research Center, Mumbai, India

Further details soon

David Rubinow
David Rubinow
MD, University of North Carolina, Chapel Hill, NC, USA

Dr. Rubinow is Distinguish Professor and Chair Emeritus of the Department of Psychiatry at the University of North Carolina (UNC)-Chapel Hill, School of Medicine. He was the founding Director of the UNC Center for Innovation and Health Care System Transformation as well as founding Director of the UNC Women’s Mood Disorder Program. Previously, he was the Clinical Director of the National Institute of Mental Health (NIMH) and founding Chief of the Behavioral Endocrinology Branch of NIMH. HIs research interests focus on neurobehavioral effects of gonadal steroids.

Dr. Rubinow has received awards for his research (e.g., A.E. Bennett Neuropsychiatric Research Foundation Award; Research Award of the Academy of Psychosomatic Medicine; Gold Medal Award of the Society of Biological Psychiatry, Mood Disorders Research Award of the American College of Psychiatrists, Menninger Award of the American College of Physicians), clinical supervision/training (NIH Distinguished Clinical Educator Award; NIMH Mentor of the Year 2002) and scientific administration (USPHS Outstanding Service Medal). He served as President of the American College of Neuropsychopharmacology and the Society of Biological Psychiatry. He was inducted into the National Academy of Medicine in 2012.

Pierre Schulz
Pierre Schulz
MD, Clinical Psychopharmacology Unit, Geneva, Switzerland

Further details soon

Margret Hoehe
Margret Hoehe
MD, PhD, Max Planck Institute for Molecular Genetics, Berlin, Germany

Genome Research Group Leader, Max Planck Institute for Molecular Genetics, Berlin (2002 – 2017); Adjunct Faculty, The Rockefeller University, New York (2005 – 2006); Independent Research Group Leader, Max-Delbrück-Center for Molecular Medicine (MDC) (Associate Professor level), Berlin (1994 – 2001); Senior Principal Investigator in all phases of the German Human Genome Project and other major research programs of the Federal Ministry of Education and Research (BMBF) (1996 – 2012).

Studied human medicine and psychology at the Ludwig-Maximilians-University Munich, MD; PhD in neuroendocrinology/-pharmacology; Diploma in Psychology; scholarship recipient of the “Studienstiftung des deutschen Volkes“ (awarded to the top 0.5% of university students). Professional experience/positions include Scientific Assistant, Neurochemical Department, Psychiatric Hospital, University of Munich (1982 – 1987); Senior Staff Fellow, Clinical Neurogenetics Branch, National Institute of Mental Health (NIMH), National Institutes of Health (NIH), Bethesda (1987 – 1992) and Department of Genetics, Laboratory George M. Church, Harvard Medical School, Boston (1992 – 1994).

Pioneered research on human genetic variation, haplotypes and diploid genomes; de novo development and application of DNA sequencing technologies; molecular genetics and bioinformatics approaches to haplotype-resolve diploid genomes; genetics and genomics of disease; pharmacogenomics, individualized medicine. Numerous publications and patents.

https://www.mpg.de/5720980/W003_Biology-Medicine_064-071.pdf